中国医疗前沿
中國醫療前沿
중국의료전연
CHINA HEALTHCARE INNOVATION
2013年
22期
37-37,67
,共2页
中西医结合%肝炎肝硬化%顽固性腹水
中西醫結閤%肝炎肝硬化%頑固性腹水
중서의결합%간염간경화%완고성복수
CM with Western medicine%Hepatitis cirrhosis%Refractory ascites
目的:探讨中西医结合治疗肝炎肝硬化顽固性腹水的临床疗效。方法将80例肝硬化顽固性腹水患者根据治疗适应症和家属意见分为观察组52例和对照组28例,对照组患者给予常规限钠、保肝、补充血浆及白蛋白、利尿、防治感染等治疗,观察组在此基础上给予自拟中药方治疗,疗程结束后判定两组疗效。结果观察组总有效率高于对照组(P <0.05);与对照组比较,观察组治疗后AST、A、GA等指标改善得更明显(P <0.05)。结论中西医结合治疗肝炎肝硬化顽固性腹水能取得很好疗效,值得临床应用。
目的:探討中西醫結閤治療肝炎肝硬化頑固性腹水的臨床療效。方法將80例肝硬化頑固性腹水患者根據治療適應癥和傢屬意見分為觀察組52例和對照組28例,對照組患者給予常規限鈉、保肝、補充血漿及白蛋白、利尿、防治感染等治療,觀察組在此基礎上給予自擬中藥方治療,療程結束後判定兩組療效。結果觀察組總有效率高于對照組(P <0.05);與對照組比較,觀察組治療後AST、A、GA等指標改善得更明顯(P <0.05)。結論中西醫結閤治療肝炎肝硬化頑固性腹水能取得很好療效,值得臨床應用。
목적:탐토중서의결합치료간염간경화완고성복수적림상료효。방법장80례간경화완고성복수환자근거치료괄응증화가속의견분위관찰조52례화대조조28례,대조조환자급여상규한납、보간、보충혈장급백단백、이뇨、방치감염등치료,관찰조재차기출상급여자의중약방치료,료정결속후판정량조료효。결과관찰조총유효솔고우대조조(P <0.05);여대조조비교,관찰조치료후AST、A、GA등지표개선득경명현(P <0.05)。결론중서의결합치료간염간경화완고성복수능취득흔호료효,치득림상응용。
Objective To observe the clinical effects of TCM with Western medicine in treating refractory ascites in patients of hepatitis cirrhosis. Methods According to the treatment indications and families advices, 80 cases refractory ascites were divided into observation group and control group. 52 cases of observation group were treated with TCM with Western medicine, 28 cases of control group with local medication. Results The total effective rate in the observation group was significantly higher than in control group(P <0.05). The observation group's with AST, A, G improve were better than the control group(P <0.05). Conclusion It is efficacy and safety of TCM with Western medicine in treating refractory ascites in patients of hepatitis cirrhosis and worthy of clinical application.